Searched for
FOSUN GROUP
After AI, China unicorns are eyeing global domination in robotic humanoidsLinkerbot currently holds over 80 per cent of the global market share in high-degree-of-freedom (DoF) robotic hands.- Bay Capital launches digital fund, appoints Sandeep Barasia, Tej Kapoor as partnersBay Capital is launching a Digital Opportunities Fund to invest in public and private digital businesses in India. Sandeep Barasia and Tej ...
- Fosun to pare stake in Gland PharmaShanghai-based Fosun Pharmaceutical Group, the promoter of Gland Pharma, plans to sell up to a 5% stake in the company through a block deal...
- Fosun drops plan to sell stake in Gland Pharma: ReportShares of Gland Pharma were up 0.8% at 1,360 rupees as of 9:50 a.m. IST. They have plunged 28% since November end, when Bloomberg News had ...
- Fosun Said to Mull Sale of India’s $3.6 Billion Gland PharmaA sale would help Gland’s Chinese owner raise cash as the once-acquisitive group seeks to shore up its balance sheet. Fosun International h...
- Gland Pharma rallies 9% as Fosun mulls selling controlling stake in firmA sale would help Gland’s Chinese owner raise cash as the once-acquisitive group seeks to shore up its balance sheet. Fosun International h...
- Chinese-owned Gland Pharma re-appoints Srinivas Sadu as MD & CEOGland Pharma reported revenues of Rs 3463 and a net profit of Rs 997 crore in FY21. Shares of Gland Pharma rose 1.89% to close at Rs 3360 o...
- Chinese firm-backed Gland Pharma files for IPO; may raise up to Rs 6,000 croreThe company may raise up to $800 million or Rs 6,000 crore, a source with the knowledge of the matter said.
- Fosun invests 800 crore in realty venture with Ahuja ConstructionsDeal is the first realty transaction in the country by a Chinese group
- PerkFinance raises seed round of $900,000Others who participated in the round were Krishna Vinjamuri, a former VC with Lightbox and Sherpalo and Karan Virwani, CEO of WeWork India.
- Fosun targets Fortis: A white knight or a dark horse?Often known as China's Warren Buffett, Guo Guangchang prefers to be his student instead. His mysterious disappearance last year raised many...
- China’s Fosun eyes stake in Ahuja ConstructionsThe Fosun Group is amongst China’s largest privately-owned investment conglomerates with interests spanning across pharmaceuticals, real es...
- Nitesh Estates soars 20% in early trade; here’s whyThe scrip jumped 19.95 per cent to its fresh 52-week high of Rs 15.93 on Thursday.
- Fosun Pharma acquires 74% stake in Gland Pharma for $1.09 billionFosun Pharma and Fosun International indirectly hold approximately 74 per cent equity interest in Gland Pharma, the joint statement added.
- Fosun Group injects new life into Gland Pharma dealLast year, the government relaxed the foreign investment rules, allowing global companies to acquire up to 74 per cent in local drug makers...
- Fosun agrees to buy KKR-backed Gland Pharma for $1.4 billion: SourceThe deal would be the first major move by the Fosun group since Guo Guangchang, founder of flagship holding firm Fosun International Ltd an...
- China's Shanghai Fosun to acquire 86% stake in Gland Pharma for $1.4 billionShanghai Fosun will acquire the shares held by Gland Pharma founders Ravi Penmetsa and his family and PE giant KKR.
- China's Fosun to buy KKR backed Gland Pharma for $1.4 billionFosun has agreed to acquire 96 percent stake, which includes shares held by founders of Gland Pharma Ravi Penmetsa and family and private e...
- Fosun leads the race to buy Gland Pharma with $1.27 billion bidComing from behind in a closely fought race that saw US giant Baxter and private equity fund Advent make firm offers early May, Hong Kong-l...
- China stocks slump as report of missing billionaire Guo Guangchang compounds woesThe Hang Seng China Enterprises Index retreated for a seventh day, led by industrial and power companies.
Load More
